Correspondence 0001104659-23-064694 from BELITE BIO, INC (BLTE) (CIK 0001889109) (BLTE)
BELITE BIO, INC (BLTE) (CIK 0001889109)
Date: May 25, 2023 · CIK: 0001889109 · Accession: 0001104659-23-064694
AI Filing Summary & Sentiment
File numbers found in text: 333-272125
Letter
May 25,
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
F Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes
Re: BELITE BIO, INC.
Registration Statement on Form F-3
Filed May 22, 2023
File No. 333-272125
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 of the Rules and Regulations of the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Belite Bio, Inc (the “Company”), hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-3 (the “Registration Statement”) be accelerated to, and that the Registration Statement become effective at, 9:00 AM (Eastern time) on May 30, 2023, or as soon thereafter as practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Robert Plesnarski (+1 (202) 383-5149) or Portia Ku (+1 (212) 326-2168) of O’Melveny & Myers LLP, counsel to the Company. Thank you for your assistance with this matter.
[Signature page follows]
Very truly yours,
BELITE
BIO, INC
Show Raw Text
CORRESP
1
filename1.htm
May 25,
2023
VIA EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Tyler Howes
Re:
BELITE BIO, INC.
Registration
Statement on Form F-3
Filed May 22, 2023
File No. 333-272125
Ladies and Gentlemen:
Pursuant
to Rules 460 and 461 of the Rules and Regulations of the U.S. Securities and Exchange Commission (the “Commission”)
under the Securities Act of 1933, as amended, Belite Bio, Inc (the “Company”), hereby requests that the effectiveness
of the above-referenced Registration Statement on Form F-3 (the “Registration Statement”) be accelerated to,
and that the Registration Statement become effective at, 9:00 AM (Eastern time) on May 30, 2023, or
as soon thereafter as practicable.
Once the Registration
Statement has been declared effective, please orally confirm that event with Robert Plesnarski (+1 (202) 383-5149) or Portia Ku (+1 (212)
326-2168) of O’Melveny & Myers LLP, counsel to the Company. Thank you for your assistance with this matter.
[Signature page follows]
Very truly yours,
BELITE
BIO, INC
By: /s/ Yu-Hsin Lin
Name:
Yu-Hsin Lin
Title: Chief
Executive Officer and Chairman